Results from a polarized Analysis of Safety Data of an adjuvanted Herpes Zoster Subunit Vaccine Candidate consisting of more than 14,500 Study Participants from the Age of 50 Years
Por:
Lopez-Fauqued, M, Campora, L, Delannois, F, El Idrissi, M, Ledent, E, Diez-Domingo, J, McElhaney, J, McNeil, S, De Looze, F, Yeo, W, da Silva, F and Hain, J
Publicada:
1 abr 2018
Categoría:
Internal medicine
Resumen:
|